A lubricant including an ionic liquid, which includes a conjugate acid (B.sup.+) and a conjugate base (X.sup.), and is protic, wherein the ionic liquid is represented by the following general formula (1): ##STR00001##
where R.sup.1 and R.sup.2 each represent a hydrogen atom or R.sup.1 and R.sup.2 form a benzene ring together with carbon atoms to which R.sup.1 and R.sup.2 are bonded, and R.sup.3 represents a straight-chain hydrocarbon group having 10 or more carbon atoms in the general formula (1).

A lubricant including an ionic liquid, which includes a conjugate acid (B.sup.+) and a conjugate base (X.sup.), and is protic, wherein the ionic liquid is represented by the following general formula (1): ##STR00001##
where R.sup.1 and R.sup.2 each represent a hydrogen atom or R.sup.1 and R.sup.2 form a benzene ring together with carbon atoms to which R.sup.1 and R.sup.2 are bonded, and R.sup.3 represents a straight-chain hydrocarbon group having 10 or more carbon atoms in the general formula (1).

The invention relates to thiadiazine derivatives, or pharmaceutically acceptable salts, biologically active metabolites, pro-drugs, racemates, enantiomers, diastereomers, solvates and hydrates thereof, as well as to pharmaceutical compositions containing them and to their use as modulators of 7 nicotinic acetylcholine receptor activity in a mammalian subject Formula (I): ##STR00001##

The invention relates to thiadiazine derivatives, or pharmaceutically acceptable salts, biologically active metabolites, pro-drugs, racemates, enantiomers, diastereomers, solvates and hydrates thereof, as well as to pharmaceutical compositions containing them and to their use as modulators of 7 nicotinic acetylcholine receptor activity in a mammalian subject Formula (I): ##STR00001##

The present application discloses a small-molecule compound having a naphthalenethiol ether structure, and a use thereof. Disclosed in the present application are a compound having a structure represented by general formula (I), a pharmaceutically acceptable salt, a stereoisomer, a solvate or a prodrug thereof, a pharmaceutical composition containing the same, and a use thereof in the preparation of mitophagy inducer drugs. In the present application, the structure of the compound having the structure represented by general formula (I) is shown below. The compound and the pharmaceutically acceptable salt, stereoisomer, solvate or prodrug thereof, or the pharmaceutical composition provided in the present application can enhance the ability to induce mitophagy.

##STR00001##

The present application discloses a small-molecule compound having a naphthalenethiol ether structure, and a use thereof. Disclosed in the present application are a compound having a structure represented by general formula (I), a pharmaceutically acceptable salt, a stereoisomer, a solvate or a prodrug thereof, a pharmaceutical composition containing the same, and a use thereof in the preparation of mitophagy inducer drugs. In the present application, the structure of the compound having the structure represented by general formula (I) is shown below. The compound and the pharmaceutically acceptable salt, stereoisomer, solvate or prodrug thereof, or the pharmaceutical composition provided in the present application can enhance the ability to induce mitophagy.

##STR00001##

Compounds active on protein kinases are described, as well as methods of using such compounds to treat diseases and conditions associated with aberrant activity of protein kinases.

Compounds active on protein kinases are described, as well as methods of using such compounds to treat diseases and conditions associated with aberrant activity of protein kinases.

The present invention includes methods/processes and intermediates for preparing compounds having structural Formula (I):

##STR00001##

wherein X is alkyl, substituted alkyl, alkenyl, substituted alkenyl, heteroalkyl, substituted heteroalkyl, heteroalkenyl, or substituted heteroalkenyl.

The present invention includes methods/processes and intermediates for preparing compounds having structural Formula (I):

##STR00001##

wherein X is alkyl, substituted alkyl, alkenyl, substituted alkenyl, heteroalkyl, substituted heteroalkyl, heteroalkenyl, or substituted heteroalkenyl.